Fosamax Lawsuit

Fosamax (also known as alendronate) belongs to a class of drugs called bisphosphonates, and used to treat osteoporosis and Paget’s disease.

It hinders the process of bone breakdown in the human body, while increasing bone mass. It also alters the cycle of bone formation, allowing for bone strengthening over long periods of time. Bisphosphonates, such as Fosamax, can also reduce bone pain associated with breast cancer and multiple myeloma. But many Fosamax patients have experienced spontaneous femur fractures (thigh bone), while performing normal, everyday activities such as walking down steps.

Fosamax Side Effects

This bisphosphonate drug has also been linked to osteonecrosis of the jaw (“dead jaw” or “jaw death”). Osteonecrosis is a severe form of damage in the jaw where the bone tissue does not heal after minor traumas. In dental procedures, patients are at risk when they take Fosamax. Most cases occur after tooth extraction and other dental procedures.

In 2010, the Food and Drug Administration (FDA) announced that they would require drug manufacturers to include on their labels that there is a link between bisphosphonate-use and atypical femur fractures.

The Journal of the American Medical Association published an article in 2011 stating that patients who took bisphosphonates for five years or longer were at increased risk for femur fractures.

Patients who have experienced adverse side-effects from taking Fosamax may have legal recourse.